ITGAM and neoplasm: Tumor-infiltrating myeloid-derived suppressor cells (MDSC) dually expressing CD11b and Gr-1 have been shown to contribute to the development of resistance to several forms of treatment, including antiangiogenic agents that target VEGF receptor signaling [5-11].